CN1626545A - 一种从文冠果壳和柄中提取的化合物及提取方法和应用 - Google Patents
一种从文冠果壳和柄中提取的化合物及提取方法和应用 Download PDFInfo
- Publication number
- CN1626545A CN1626545A CNA2004100591402A CN200410059140A CN1626545A CN 1626545 A CN1626545 A CN 1626545A CN A2004100591402 A CNA2004100591402 A CN A2004100591402A CN 200410059140 A CN200410059140 A CN 200410059140A CN 1626545 A CN1626545 A CN 1626545A
- Authority
- CN
- China
- Prior art keywords
- compound
- solvent
- shinyleaf yellowhorn
- handle
- xanthoceraside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 39
- 244000248162 Xanthoceras sorbifolium Species 0.000 title claims abstract description 38
- 235000009240 Xanthoceras sorbifolium Nutrition 0.000 title claims abstract description 38
- 238000000605 extraction Methods 0.000 title claims abstract description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 36
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000002904 solvent Substances 0.000 claims abstract description 19
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000000126 substance Substances 0.000 claims abstract description 13
- 229930182490 saponin Natural products 0.000 claims abstract description 12
- 150000007949 saponins Chemical class 0.000 claims abstract description 12
- 238000010828 elution Methods 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 208000014644 Brain disease Diseases 0.000 claims abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 7
- 239000011347 resin Substances 0.000 claims abstract description 7
- 229920005989 resin Polymers 0.000 claims abstract description 7
- 238000010898 silica gel chromatography Methods 0.000 claims abstract description 7
- 239000007787 solid Substances 0.000 claims abstract description 7
- 238000007670 refining Methods 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 16
- 235000013399 edible fruits Nutrition 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 11
- 206010028980 Neoplasm Diseases 0.000 claims description 11
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 10
- 235000017709 saponins Nutrition 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 7
- 238000002386 leaching Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 238000004090 dissolution Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 230000036541 health Effects 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims 1
- 241000612118 Samolus valerandi Species 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 2
- 238000001704 evaporation Methods 0.000 abstract description 2
- 208000003174 Brain Neoplasms Diseases 0.000 abstract 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract 2
- 239000012141 concentrate Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000003480 eluent Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 229930182470 glycoside Natural products 0.000 abstract 1
- 150000002338 glycosides Chemical class 0.000 abstract 1
- 235000013402 health food Nutrition 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- 229910052739 hydrogen Inorganic materials 0.000 description 14
- 239000001257 hydrogen Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000470 constituent Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 239000002023 wood Substances 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 239000002504 physiological saline solution Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 210000004881 tumor cell Anatomy 0.000 description 4
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 3
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- 125000005601 angeloyl group Chemical group 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 244000309464 bull Species 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000002547 new drug Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000000452 restraining effect Effects 0.000 description 3
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 3
- 229960002646 scopolamine Drugs 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229930182493 triterpene saponin Natural products 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 238000012404 In vitro experiment Methods 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 201000000498 stomach carcinoma Diseases 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 241001632409 Aralia elata Species 0.000 description 1
- 235000015888 Aralia elata Nutrition 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 241000209507 Camellia Species 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DREXRFWZUBSPBF-UHFFFAOYSA-N N#CN.[S] Chemical compound N#CN.[S] DREXRFWZUBSPBF-UHFFFAOYSA-N 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 241001093760 Sapindaceae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 241000408907 Xanthoceras Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 229930193445 elatoside Natural products 0.000 description 1
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 1
- 238000003929 heteronuclear multiple quantum coherence Methods 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 208000005346 nocturnal enuresis Diseases 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- OILHVNROWDFZDW-UHFFFAOYSA-N prosapogenin Natural products CC1(C)CCC2(C(O)CC3(C)C(=CCC4C5(C)CCC(OC6OC(CO)C(O)C(O)C6O)C(C)(C=O)C5CCC34C)C2C1)C(=O)O OILHVNROWDFZDW-UHFFFAOYSA-N 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- 238000001551 total correlation spectroscopy Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 动物数(只) | 剂量(mg/kg) | 错误反应次数x±SD | P |
生理盐水 | 10 | 等剂量 | 28.2±4.4 | - |
文冠果壳苷 | 10 | 9 | 6.9±2.3 | <0.01 |
组别 | 动物数(只) | 剂量(mg/kg) | 错误反应次数x±SD | P |
生理盐水 | 8 | 等剂量 | 17.9±3.6 | - |
文冠果壳苷 | 8 | 6 | 4.0±1.5 | <0.01 |
指标 | 对照组 | 给药组 | P |
第一批 xt(min)xp(min)xp- xc(min)第二批 xt(min)xp(min)xp- xc(min) | 34.3±8.89(30※)41.42±4.48(14)5.54±4.46(14)25.38±4.24(40)27.54±2.87(24)2.64±2.87(24) | 41.84±15.35(30※)56.51±14.59(17)14.59±14.83(17)3 1.55±6.68(41)33.40±4.94(33)8.40±4.94(33) | <0.025<0.05<0.05<0.001<0.001<0.001 |
序号 | 测试模型 | 剂量(ug/ml) | 观察指标 | 测试效应 | 结果 | IC50(ug/ml) |
123456 | MTT法(HL-60人白血病)SRB法(PC-3MIE8人***癌)SRB(BGC-823人胃癌)SRB法(MDA-MB-435-人乳腺癌)SRB法(Bel-7402人肝癌)SRB法(Hela人***) | 0.55.050.00.55.050.00.55.050.00.55.050.00.55.050.00.55.050.0 | 抑制率(%)抑制率(%)抑制率(%)抑制率(%)抑制率(%)抑制率(%) | 9.3417.6856.90-13.90-7.6392.03-11.71-5.9292.45-4.502.9293.14-9.78-1.2492.96-12.72-4.0595.49 | ++++++ | 41.2940.9840.2418.5839.3234.23 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100591402A CN1281616C (zh) | 2004-07-07 | 2004-08-13 | 一种从文冠果壳和柄中提取的化合物及提取方法和应用 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200410020921 | 2004-07-07 | ||
CN200410020921.0 | 2004-07-07 | ||
CNB2004100591402A CN1281616C (zh) | 2004-07-07 | 2004-08-13 | 一种从文冠果壳和柄中提取的化合物及提取方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1626545A true CN1626545A (zh) | 2005-06-15 |
CN1281616C CN1281616C (zh) | 2006-10-25 |
Family
ID=34796383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100591402A Expired - Fee Related CN1281616C (zh) | 2004-07-07 | 2004-08-13 | 一种从文冠果壳和柄中提取的化合物及提取方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1281616C (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007079695A1 (fr) * | 2006-01-12 | 2007-07-19 | Liu Shujun | Extrait de xanthoceras sorbifolia bunge et extraction et utilisation |
CN102018718A (zh) * | 2010-12-06 | 2011-04-20 | 杨柏珍 | 一种文冠果壳苷化合物的应用 |
CN101139369B (zh) * | 2007-09-10 | 2011-08-17 | 辽宁中医药大学 | 一种文冠果果壳总皂苷提取物的制备方法 |
CN102180940A (zh) * | 2011-04-02 | 2011-09-14 | 沈阳药科大学 | 一种化合物文冠果壳苷的制备方法 |
CN102783654A (zh) * | 2012-09-04 | 2012-11-21 | 山东理工大学 | 一种文冠果皂甙提取物在减肥降脂领域的应用 |
CN102813214A (zh) * | 2012-09-04 | 2012-12-12 | 山东理工大学 | 文冠果皂甙在降脂减肥领域的应用及其制备方法 |
CN102823873A (zh) * | 2012-09-04 | 2012-12-19 | 山东理工大学 | 文冠果黄酮在美白领域的应用及其制备方法 |
CN103509077A (zh) * | 2012-06-15 | 2014-01-15 | 沈阳药科大学 | 三萜皂苷类化合物及其制备方法和用途 |
CN107137501A (zh) * | 2017-05-27 | 2017-09-08 | 山西双林富农林开发有限公司 | 一种治疗脚气、脚臭的中药组合物、制剂及其制备方法 |
-
2004
- 2004-08-13 CN CNB2004100591402A patent/CN1281616C/zh not_active Expired - Fee Related
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007079695A1 (fr) * | 2006-01-12 | 2007-07-19 | Liu Shujun | Extrait de xanthoceras sorbifolia bunge et extraction et utilisation |
CN101139369B (zh) * | 2007-09-10 | 2011-08-17 | 辽宁中医药大学 | 一种文冠果果壳总皂苷提取物的制备方法 |
CN102018718A (zh) * | 2010-12-06 | 2011-04-20 | 杨柏珍 | 一种文冠果壳苷化合物的应用 |
CN102180940A (zh) * | 2011-04-02 | 2011-09-14 | 沈阳药科大学 | 一种化合物文冠果壳苷的制备方法 |
CN103509077A (zh) * | 2012-06-15 | 2014-01-15 | 沈阳药科大学 | 三萜皂苷类化合物及其制备方法和用途 |
CN103509077B (zh) * | 2012-06-15 | 2015-08-05 | 沈阳药科大学 | 三萜皂苷类化合物及其制备方法和用途 |
CN102783654A (zh) * | 2012-09-04 | 2012-11-21 | 山东理工大学 | 一种文冠果皂甙提取物在减肥降脂领域的应用 |
CN102813214A (zh) * | 2012-09-04 | 2012-12-12 | 山东理工大学 | 文冠果皂甙在降脂减肥领域的应用及其制备方法 |
CN102823873A (zh) * | 2012-09-04 | 2012-12-19 | 山东理工大学 | 文冠果黄酮在美白领域的应用及其制备方法 |
CN107137501A (zh) * | 2017-05-27 | 2017-09-08 | 山西双林富农林开发有限公司 | 一种治疗脚气、脚臭的中药组合物、制剂及其制备方法 |
CN107137501B (zh) * | 2017-05-27 | 2020-12-08 | 山西双林富农林开发有限公司 | 一种治疗脚气、脚臭的中药组合物、制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1281616C (zh) | 2006-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10160780B2 (en) | Compound extracted from husk and fruit stem of Xanthoceras sobifolia and its extracting method and use thereof | |
CN1891240A (zh) | 一种含多种灵芝活性成分的中药组合物及其制备方法 | |
CN104341430A (zh) | 一种土甘草a及其提取方法和用途 | |
CN103800390A (zh) | 具有增强免疫力及保肝功能的保健品及其制备方法与应用 | |
CN1457808A (zh) | 一种铁皮石斛复方制剂及制备和应用 | |
CN1281616C (zh) | 一种从文冠果壳和柄中提取的化合物及提取方法和应用 | |
CN1724529A (zh) | 高纯度蛇床子素及其制备方法和以该化合物为活性成分的药物组合物 | |
CN103360452B (zh) | 甜瓜蒂四环三萜葫芦素类化合物的制备和应用 | |
CN102875615B (zh) | ***药苷a和***药总皂苷的提取方法及其应用 | |
CN1303098C (zh) | 假马齿苋皂苷化合物、总皂苷及其在医药中的应用 | |
CN102477041A (zh) | 一种盐酸千金藤素的制备方法 | |
CN101085804A (zh) | 灰毡毛忍冬次皂苷乙的制备方法及其治疗肝癌、乳腺癌、子***的应用 | |
CN1323793A (zh) | 荆芥内酯及其提取工艺和用途 | |
CN1709903A (zh) | 皂苷类化合物及其苷元在制备治疗神经元损伤药物中的应用 | |
CN100350902C (zh) | 含有来自红豆杉的木聚糖类的降血糖剂、保肝药、抗癌剂 | |
CN100341888C (zh) | 霞草苷i化合物在制药中的应用 | |
CN103275139B (zh) | 十六碳双乙酰化一个双键内酯型槐糖脂及其应用 | |
CN103275138B (zh) | 十六碳双乙酰化无双键内酯型槐糖脂及其应用 | |
CN1582970A (zh) | 一种从蝼蛄中提取的抗肿瘤有效部位及制备方法 | |
CN1733093A (zh) | 一种地乌总皂苷的制备方法 | |
CN1850837A (zh) | 9-(1, 3-苯并二恶茂基-5)-4-(β-D-吡喃葡氧基)-6,7-二甲氧基萘并[2, 3-C]呋喃-1[3H] 酮, 其制备方法和含有该化合物的药物组合物 | |
CN1417218A (zh) | 山奈酚衍生物及其医药用途 | |
CN1763069A (zh) | 人参皂苷Rg2的制备方法,其药物组合物及在制药中的应用 | |
CN1733748A (zh) | 环己烯酮类双环(稠环)化合物及其制备方法与用途 | |
CN1680290A (zh) | 姜酚肟及其合成与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CI03 | Correction of invention patent |
Correction item: Abstract of the description Correct: Reprint the correct prospectus summary False: Manual, abstract, publication, printing error Number: 43 Page: The title page Volume: 22 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ABSTRACT OF DESCRIPTION; FROM: ABSTRACT OF DESCRIPTION ERROR OF PRINT TO: REPUBLISH THE CORRECT ABSTRACT OF DESCRIPTION |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20061025 Termination date: 20210813 |
|
CF01 | Termination of patent right due to non-payment of annual fee |